Search - tctmd.com

Displaying 181 - 200 of 254

Sort: Relevancy | Date

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Shelley Wood

April 06, 2018

News Daily News

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Michael O'Riordan

April 04, 2018

News Daily News

More CV Hospitalizations Later in Life for Mothers of Babies With Heart Defects

Caitlin E. Cox

April 02, 2018

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Caitlin E. Cox

March 26, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

News Conference News ACC 2018

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

Yael L. Maxwell

March 10, 2018

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

News Conference News ACC 2018

Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease

Yael L. Maxwell

March 09, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Heart Rate Changes Over Time Hint at Higher Cardiovascular Risk

Michael O'Riordan

January 25, 2018

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Daily News

Cardiac Rehab Rates Still Low in Medicare and VA Populations

L.A. McKeown

January 09, 2018

News Daily News

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Yael L. Maxwell

January 09, 2018

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

Advertisement

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Respiratory Syncytial Virus Linked With Cardiovascular Complications

More CV Hospitalizations Later in Life for Mothers of Babies With Heart Defects

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Heart Rate Changes Over Time Hint at Higher Cardiovascular Risk

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Cardiac Rehab Rates Still Low in Medicare and VA Populations

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content